1) How many patients with breast implant associated ALCL (BIA-ALCL) have been treated within the trust since 2000? Please break down the figures by what year the patient was treated and which hospital the patient was treated at, where possible.
2) How many of these cases were reported to the Medicines and Healthcare products Regulatory Agency (MHRA)?
3) Have any patients with BIA-ALCL died while under treatment within the trust? If so, please give the year and the hospital if possible and whether this adverse event was reported to the MHRA.
Download response Breast implant associated ALCL (BIA-ALCL). 280319